Daniel Grau, Avilar Therapeutics CEO
Exclusive: Sanofi, Astellas venture arms add cash to Avilar's 'ATAC' mission
The venture arms of Sanofi and Astellas have grown their investment in Avilar Therapeutics to help steer the biotech through a niche of the growing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
